Invention Grant
- Patent Title: Non-invasive determination of methylome of tumor from plasma
-
Application No.: US16389753Application Date: 2019-04-19
-
Publication No.: US10706957B2Publication Date: 2020-07-07
- Inventor: Yuk-Ming Dennis Lo , Rossa Wai Kwun Chiu , Kwan Chee Chan , Miu Fan Lun , Wai Man Chan , Peiyong Jiang
- Applicant: The Chinese University of Hong Kong
- Applicant Address: HK Shatin, New Territories
- Assignee: The Chinese University of Hong Kong
- Current Assignee: The Chinese University of Hong Kong
- Current Assignee Address: HK Shatin, New Territories
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: G16B30/00
- IPC: G16B30/00 ; C12Q1/6886 ; C12Q1/6869 ; G16B20/10 ; G16B20/30 ; C12Q1/6806 ; C12Q1/686

Abstract:
Systems, methods, and apparatuses can determine and use methylation profiles of various tissues and samples. Examples are provided. A methylation profile can be deduced for fetal/tumor tissue based on a comparison of plasma methylation (or other sample with cell-free DNA) to a methylation profile of the mother/patient. A methylation profile can be determined for fetal/tumor tissue using tissue-specific alleles to identify DNA from the fetus/tumor when the sample has a mixture of DNA. A methylation profile can be used to determine copy number variations in genome of a fetus/tumor. Methylation markers for a fetus have been identified via various techniques. The methylation profile can be determined by determining a size parameter of a size distribution of DNA fragments, where reference values for the size parameter can be used to determine methylation levels. Additionally, a methylation level can be used to determine a level of cancer.
Public/Granted literature
- US20190241979A1 NON-INVASIVE DETERMINATION OF METHYLOME OF TUMOR FROM PLASMA Public/Granted day:2019-08-08
Information query